Daily single-strength vs. thrice-weekly double-strength trimethoprim/sulfamethoxazole for Pneumocystis jirovecii prophylaxis in kidney transplant recipients: a non-inferiority randomized control trial
Abstract Background Pneumocystis jirovecii pneumonia (PJP) is a significant concern in kidney transplant (KT) recipients, with trimethoprim/sulfamethoxazole (TMP/SMX) as the recommended prophylaxis. However, direct comparisons between daily single-strength (DSS) and thrice-weekly double-strength (TD...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2025-10-01
|
| Col·lecció: | BMC Infectious Diseases |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12879-025-11821-6 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|